Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc.

RADNOR, Pennsylvania, July 7, 2021 (GLOBE NEWSWIRE) – Law firm Kessler Topaz Meltzer & Check, LLP reminds investors that class actions against securities fraud have been filed in the United States District Court for the Western District of Washington at Athira Pharma, Inc. ( NASDAQ: ATHA) (“Athira”) on behalf of those who have bought or acquired Athira common stock: a) in accordance with and / or traceable to the registration statement and prospectus (collectively the “Registration Statement”) issued in connection with Athira’s IPO in September 2020; and / or b) between September 18, 2020 and June 17, 2021, including (the “Class Period”).

Deadline of the main plaintiff: August 24, 2021

Athira is a late-stage clinical biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration.

The complaints allege that the defendants made materially false and misleading statements in the registration statement and / or throughout the collection period and failed to state that: (1) Athira’s President and Chief Executive Officer, Dr, altered images during her studies; (2) this alleged research was fundamental to Athira’s efforts to develop treatments for Alzheimer’s as it laid the biological foundations that Athira used in his approach to treating Alzheimer’s; (3) As a result, Athira’s intellectual property and product development for the treatment of Alzheimer’s were based on invalid research; and (4) as a result of the foregoing, Defendants’ positive statements about Athira’s business, business and prospects were materially misleading and / or unfounded.

The story goes on

Impact investors can by 08/24/2021 at the latest, attempt to be appointed as lead class representative by Kessler Topaz Meltzer & Check, LLP, or other legal counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in the conduct of the dispute. To be appointed as a lead plaintiff, the court must determine that the class plaintiff’s claim is typical of the claims of other class plaintiffs and that the class plaintiff is adequately representing the class action. Your ability to participate in a recovery will not be affected by whether or not you want to be the lead plaintiff.

Kessler Topaz Meltzer & Check, LLP pursues class actions in state and federal courts across the country involving securities fraud, fiduciary violations, and other violations of state and federal laws. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform and has collected billions of dollars on behalf of institutional and private investors from the US and around the world. The firm represents investors, consumers and whistleblowers (individuals who report fraudulent practices to the government and participate in recovery of government dollars). The complaint in this lawsuit was not filed by Kessler Topaz Meltzer & Check, LLP. For more information on Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

CONTACT:

Kessler Topas Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 König-von-Preußen-Strasse
Radnor, PA 19087
(844) 887-9500 (toll free)
[email protected]

Comments are closed.